"Promoting and supporting research into diabetes
and metabolic diseases".

For the advancement of diabetes research

In the spotlight

FFRD updates and presentation of the 2024 awardees to the press!

 

As every year begins, the FFRD is delighted to showcase its awardees and their projects while reflecting on the key moments of 2024:

 

  • €8.3 million distributed since 2013

  • 31 Francophones awardees recognized
  • The FFRD supports all diabetes research fields: clinical, translational and fundamental
  • Focus on research advances and type 1 diabetes
  • 1st FFRD symposium on the B cell, at the 2024 SFD congress in Toulouse
  • The SFDT1 study, led by the FFRD, continues to grow!
  • Discussions with researchers and key players in Francophone diabetes research

 

Exciting news for 2025 from the FFRD…

New governance, a new call for projects and new timeline, a new FFRD symposium on the gut microbiota at the SFD congress in Paris and new partnerships on the horizon!

 

DISCOVER OUR PRESS RELEASE!

News

The upcoming events of the FFRD

17
Feb
Launch of the FFRD 2025 Call for Projects

2 or 3 projects for a total of €600,000, funded by the FFRD
Clinical, basic, and translational research
Teams of Francophone researchers

18
Feb
Board webconference

Definition of the New 2025 Strategy
Development of the Specifications Document
Implementation of actions

President’s foreword

Diabetes mellitus affects 5% of the French population and is a major burden for the persons living with this chronic disease, with potentially serious complications and high costs induced. Major and continuous improvements have been made for a botter understanding of the mechanisms of the disease and its complications, and for its monitoring and treatment as well.

The FFRD supports all research on diabetes.

The FFRD supports clinical, basic, and translational research.

The supported basic research projects address major themes of type 1 and type 2 diabetes

covering subjects such as pancreatic beta cells, insulin resistance, and intestinal microbiota.

The clinical research projects, on the other hand, address the themes of type 1 and type 2 diabetes, as well as gestational diabetes

and often involve large multicenter cohort studies.

Since 2013, the Foundation has been:

0
years of existence
0
teams of supported researchers
0
euros in annual grants
0
million of euros distributed
0
% of expenses allocated to research

The recipients of the year

Pierre GOURDY
Pierre GOURDY
Cardiovascular and Metabolic diseases Institute, Inserm, CHU in Toulouse
Translational Research Project
300 000
Alfonso GALDERISI
Alfonso GALDERISI
Robert Debré, Hospital, University Paris Cité
Clinical Research Project
300 000

They support us